Background Monitoring 6-thiopurine S-methyltransferase (TPMT; EC 2.1.1.67) activity is especially important when patients are treated with 6-thiopurine drugs, since severe bone marrow toxicity may be induced if patients have deficient TPMT activity.
Introduction
6-Thiopurine S-methyltransferase (TPMT; EC 2.1.1.67) is an important enzyme in the metabolism of 6mercaptopurine (6MP) and azathioprine. 6MP is a well known drug in the treatment of acute lymphoblastic leukaemia (ALL). 1 Azathioprine is widely used as an immunosuppressive agent in rheumatological diseases, a variety of dermatological conditions, gastroenterology, neurology, Beh ¹c cet's disease and during follow-up treatment of renal transplantation and other tissue transplants. 2^6 It is converted rapidly to 6MP in vivo and may be further converted by various pathways: it may be metabolized to 6-thioguanine nucleotides, a multi-step conversion initially catalysed by hypoxanthine -guanine phosphoribosyltransferase; it may be converted to 6mercapto-8-hydroxypurine and thiouric acid by xanthine dehydrogenase; or it may be 6-S-methylated to 6-methylmercaptopurine (6MeMP) by TPMT. 7 It is known that a marked variation exists in TPMT activity between individuals, controlled by an allelic polymorphism for either normal or de¢cient enzyme activity. 8^10 The frequency distribution of TPMT activity is tri-modal. In a normal population 84 -89% is homozygous for the wild-type (TPMT*1/*1) allele, whereas only 0¢3% has mutations in both alleles and the remaining 6-11% of the population is heterozygous with one allele a¡ected. The genetic polymorphism of TPMT becomes signi¢cant when patients are treated with 6MP or azathioprine. Patients with completely de¢cient TPMT activity, and also some heterozygous individuals, are at risk of profound myelotoxicity when treated with azathioprine or 6MP. 2,11^14 It has recently been reported that in rheumatoid arthritis, inherited intermediate TPMT activity seems to be predictive for the development of severe side-e¡ects from azathioprine. 15 On the other hand, individuals homozygous for TPMT*1/*1 may be less e¡ectively treated with standard dosages of oral 6MPor azathioprine. 14, 16, 17 In addition, it has also been shown that TPMT activities in RBC may be induced during maintenance treatment of ALL with 6MP. 18 In order to measure TPMT activity for diagnostic and research purposes, it was necessary to develop a quick and reliable method. The results obtained using this method were then compared with the results obtained using other methods and reference values were determined.
Materials and methods

Reference material
To establish reference values, hepariniz ed blood was taken from control patients in our paediatric department, following written informed consent by the patients and/or their parents/guardians. Chemicals 6-mercaptopurine, 6MeMP, S-adenosylmethionine (SAM), dithiothreitol and allopurinol were purchased from Sigma (St Louis MO, USA). All other chemicals were obtained from Merck (Darmstadt, Germany). The water used for all bu¡ers was puri¢ed in a Milli-Q System (Millipore, Bedford MA, USA).
Cell isolation and cell preparation
Erythrocytes (RBC) were isolated from 5 mL of heparinized blood, suspended in phosphate -bu¡ered 0¢9% saline (PBS; total volume 5 mL) and centrifuged at room temperature for 10 min at 160 g. The RBC were resuspended in 5 mL of PBS and centrifuged for 10 min at 160 g. This procedure was repeated once more, but with centrifugation at 640 g. The supernatant was removed, 2 mL of PBS were added to the RBC pellet, the cells were suspended again and counted with a Coulter Counter (Model Z1, Coulter Electronics, Luton, UK). The RBC were lysed by the addition of 2 mL of RBC suspension to 6 mL of ice cold water in a 15-mL tube. After stirring well, the lysate was kept on ice for 10 min and then divided into 2-mL aliquots. The aliquots were centrifuged at 48C for 10 min at 14 000 g. From each aliquot 1mL of the supernatant was collected in an Eppendorf tube and stored at ¡808C until further measurement.
To compare activity based on number of cells with activity based on protein, the amount of lysed RBC was measured and the protein content of the lysate was measured by Lowry's method. The analyses were performed on samples from a subset of10 patients with ALL and from 10 control patients.
For the preparation of peripheral blood mononuclear cells (pMNC), heparinized venous blood (5 mL) was immediately processed by Ficoll-Isopaque isolation according to the procedure described earlier. 19 An equal volume of PBS was added to the heparinized blood and 8 mL of this suspension were carefully layered on top of a density gradient, consisting of 4 mL of Lymphoprep (density 1¢077 g/mL; Nycomed) and centrifuged (Hettich Universal 30 RF, Hettich Zentrifugen, Tuttlingen, Germany) at room temperature for 20 min at 1000 g. pMNC were collected from the interphase, washed with an equal volume of PBS and centrifuged at room temperature for 5 min at 825 g. Contaminating RBC were eliminated by suspending the cell pellet in 10 mL of RBC shock solution, consisting of 70 mmol/ LTris -HCl and155 mmol/L NH 4 Cl (1:9 v/v, pH 7¢2-7¢4). The suspension was incubated in a waterbath for 15 min at 37 8C and then centrifuged at room temperature for 5 min at 825 g. The cell pellet was resuspended and washed twice in approximately 15 mL of PBS and centrifuged after each washing step at 208C for 5 min at 825 g. The cell pellet was then suspended in 1¢25 mL of a solution containing PBS plus 4% bovine serum albumin and stored on ice until cell counts were performed. Numbers of white blood cells were determined with a Coulter Counter. Cell viability was monitored by staining with trypan blue (normally 95+3%).
Lymphoblasts of the Molt-F4 T-ALL cell line were cultured according to the previously described procedure, 20 with some modi¢cations. The cells were cultured in RPMI 1640 medium with Glutamax-1 (Gibco) supplemented with 10% fetal calf serum, 2 mmol/ L sodium pyruvate (BDH Chemicals Ltd, UK) and gentamicin (50 mg/mL; Invitrogen, UK).
The numbers of pMNC or Molt-F4 cells were then counted and corrected for cell viability. The required numbers of cells were collected in Eppendorf tubes (the exact number was noted). The cells were freezedried and stored at ¡808C until enzyme incubations were performed.
Enzyme incubation
The following solutions were prepared: Solution A: 150 mmol/ L potassium phosphate bu¡er, pH 7¢5. Solution B: bu¡er containing 750 mmol/L SAM+ 3¢75 mmol/ L DL-dithiothreitol+300 mmol/L allo-purinol+150 mmol/ L potassium phosphate, pH 7¢5. Solution C: bu¡er containing 100 mmol/L SAM+ 500 mmol/L dithiothreitol+40 mmol/L allopurinol+ 150 mmol/ L potassium phosphate, pH 7¢5. Solution D: 67 mmol/ L 6MP in dimethyl sulphoxide (DMSO). Solution E: 225 mmol/ L 6MP in DMSO.
The enzyme assays from patients' samples were measured in triplicate at least.
Enzyme incubations of RBC, pMNC and Molt-F4 cells were performed according to the following procedures.
Erythrocytes
The incubation was initiated by adding 100 mL of RBC lysate to 125 mL of incubation mixture (consisting of 102 mL of solution A+15 mL of solution B+8 mL of solution D). An enzyme blank was performed using 100 mL of PBS instead of 100 mL of RBC lysate. A substrate blank was included using 8 mL of DMSO instead of 8 mL of solution D. After 2 h of incubation at 378C, the reaction was stopped with 11¢3 mL of ice-cold 8 mmol/ L HClO 4 . The samples and blanks were immediately kept on ice for 10 min and then centrifuged for 5 min at 14 000 g. The supernatants were neutralized with 4 mmol/ L K 2 HPO 4 and kept on ice for another 10 min. The neutralized samples and neutralized blanks were also centrifuged for 5 min at 14 000 g. The supernatants of this second centrifugation step were now ready for HPLC analysis.
Peripheral blood mononuclear cells and Molt-F4 cells
The enzyme reaction was initiated by addition of incubation mixture (consisting of 50 mL of solution A+50 mL of solution C+1 mL of solution E) to the freeze-dried cell pellet. The enzyme blank was performed without the freeze-dried cells, and the substrate blank (no substrate) contained 1 mL of DMSO instead of solution E. After 2 h of incubation at 378C, 5 mL of ice-cold 8 mol/L HClO 4 were added to stop the reaction. The samples and blanks were kept immediately on ice for 10 min and then centrifuged for 5 min at 14 000 g. After centrifugation, the supernatants were neutralized with 4 mol/L K 2 HPO 4 and kept on ice for another 10 min. The neutralized samples and blanks were also centrifuged for 5 min at14 000 g. The supernatants of this second centrifugation step were now ready for HPLC analysis.
High-performance liquid chromatography analysis
The analysis was performed using an automated HPLC system consisting of an autosampler (100-mL sample loop), a gradient HPLC pump, a controller, a continuous mobile phase degasser and a diode array detector (all from Waters, Millipore Corporation). 6MP and 6MeMP were separated on an Alltima reversed-phase C18 rocket HPLC column (5667 mm ID, particle size 3 mm) (Alltech, Deer¢eld IL, USA).
The samples were eluted from the HPLC column with a 50 mmol/ L KH 2 PO 4 bu¡er containing 25% methanol. The operation pressure was +90 bar and the £ow-rate was set at 2¢50 mL/min. Automatic data capture and data processing were performed using Water-Millennium-NT32 software (Waters, Millipore Corporation).
The enzyme activity was calculated from the amount of 6MeMP formed during the incubation.
Results
High-performance liquid chromatography analysis and reproducibility of the method
Chromatograms of the several cell types, obtained at a wavelength of 290 nm, showed well separated peaks of 6MeMP and 6MP. In Fig. 1 , examples of chromatographic separation are given for TPMT assays in RBC and pMNC. The retention times for 6MP and 6MeMP were 1¢0+0¢2 min and 4¢0+0¢5 min, respectively. The amounts of 6MeMP formed were calculated from peak areas of the chromatograms at 290 nm. No 6MeMP was observed in the enzyme and substrate blanks.
Calibration curves of known amounts of 6MeMP standards, dissolved in the initial elution bu¡er in concentrations ranging from 0¢1 to 4¢0 mmol/L (10-400 pmol per injection), showed a good linearity between concentration (C) of 6MeMP and peak area at 290 nm (C 6MeMPˆ1 ¢ 5556610 75 6area+0 ¢ 068 mmol/ L), with a variance coe¤cient of 0¢9985 and mean recovery+SD of 99¢7+0¢3%. The detection limit was 5 pmol per 100-mL injection.
The recoveries of standards of 6MeMP added to HClO 4 extractions of RBC lysate and freeze-dried pMNC and Molt-F4 cells were also determined. The recoveries of 6MeMP, under these conditions, were 85-96% for RBC, 89-97% for pMNC and 88-97% for Molt-F4.
Enzyme kinetics
K m and V max values for 6MP and SAM were calculated from Lineweaver-Burke plots to determine maximal substrate and co-substrate conditions for TPMT activity. The K m andV max values obtained from incubations with RBC, pMNC and Molt-F4 cells are presented in Table 1 . From these results, the optimal concentrations of 6MP (2 mmol/ L) and SAM (50 mmol/L) were calculated to measure TPMT enzyme activity in blood samples from patients and in Molt-F4 cells.
TPMT activity was evaluated for linearity between product formation and incubation time. The plots showed a good linearity during the ¢rst 3 h of incubation, with variance coe¤cients of 0¢986, 0¢992 and 0¢995 for RBC, pMNC cells and Molt-F4 cells, respectively. Similar plots were made to study the linearity between product formation and number of cells used per assay. These plots also showed a very good correlation with the number of cells analysed (rˆ0¢984 for RBC, rˆ0 ¢994 for Molt-F4 cells and rˆ0 ¢990 for pMNC). Linearity was observed between 5610 7 and 10610 7 RBC, 2610 6 and 3610 6 Molt-F4 cells and 2610 6 
(a) Substrate blank from an erythrocyte (RBC) sample; (b) thiopurine S-methyltransferase (TPMT) activity in an RBC sample; (c) substrate blank from a sample of peripheral mononuclear cells (pMNC); (d) TPMT activity in a pMNC sample. AUˆabsorbance units; 6MPˆ6-mercaptopurine; 6MeMPˆ6-methylmercaptopurine.
Two RBC samples were chosen to assess the within-run variation of the method. From these samples the RBC TPMT activity was measured 10 times during the day. The data for the two samples showed a mean+standard deviation (SD) of 15¢0+1¢4 and 22¢4+2¢0 pmol/10 7 RBC per h, respectively.
The between-day variation of the method was tested in samples from ¢ve individuals. After allowing the enzyme reaction to proceed, the reaction was stopped, Ann Clin Biochem 2003; 40: 86-93 
Figure 2. (a) Comparison of the high-performance liquid chromatography (HPLC)-based method and the radiochemical assay. Thiopurine S-methyltransferase (TPMT) activity (both axes) is expressed in pmol/10 7 RBC per h. Six samples from patients were measured by both methods. The correlation coef cient between the two methods is 0 ¢ 935. (b) Bland-Altman plot of TPMT activity {(radiochemical method+HPLC method)/2} (x-axis) plotted against the difference in activity between the radiochemical assay and the HPLC-based assay (y-axis).
neutralized, centrifuged and the supernatant stored at either 7238C or 7808C. The results from these experiments showed that the supernatants were stable for 1 week before HPLC analysis when stored at 7238C: the initial TPMT activities were 17 ¢ 2+1 ¢ 6, 38¢5+2¢4, 17¢6+2¢1, 15¢9+1¢4 and 12¢2+2¢1pmol/ 10 7 RBC per h, respectively; the corresponding TPMT activities after 7 days were 19¢2+1¢4, 36¢4+2¢1, 17¢0+1¢8, 15¢1+2¢5 and 12¢8+2¢4 pmol/10 7 RBC per h, respectively. However, storing the supernatant at 780 8C resulted in very little change in measured activity even after 25 days, when the activities were 17¢0+2¢2, 34¢0+2¢6, 15¢5+2¢4, 15¢6+1¢8 and 10¢6+1¢6 pmol/10 7 RBC per h, respectively.
Finally, the HPLC-based TPMT assay was compared with the generally used radiochemical thin-layer chromatography (TLC)-based method. 21 A fairly good correlation was observed between the two methods, with a correlation coe¤cient of 0¢935 (see Fig. 2 ).
Comparison between erythrocyte TPMT activities expressed as amount per 10 7 cells and per mg protein
In the 10 patients with ALL and the 10 controls we measured both the number of RBC and the protein content of the lysate. When TPMT activity was expressed in pmol/10 7 RBC per h and pmol/mg protein per h a good correlation was observed with a Spearman correlation coe¤cient of 0¢741 (P50¢ 001; see Fig. 3 ). However, it should be noted that with one of the higher values of the controls there was a seemingly signi¢cant di¡erence between the RBC value and the protein value.
Reference values for erythrocyte TPMT activity in children and young adults
The HPLC-based method was used to determine reference values of RBC TPMT activities in a group of 103 children and young adults (44 female and 59 male). The mean+SD value found for the female subjects was 15¢1+4¢8 pmol/10 7 RBC per h and for male subjects was 15¢8+6¢4 pmol/10 7 RBC per h. For the whole reference population a mean+SD value of 15¢5+5¢7 pmol/10 7 RBC per h was found.
The test results (P values) from two-way analysis of covariance showed no signi¢cant sex di¡erences in TPMT activity (paired t-test Pˆ0 ¢483). Also, no signi¢cant di¡erences were observed in TPMT activities when comparing children and young adults of various ages.
The frequency distribution of RBC TPMT activity in the whole control group of male and female subjects is shown in Fig. 4 . The results are consistent with the polymorphism described by others. 8, 10, 22 Ann Clin Biochem 2003; 40: 86-93 
Discussion
Evidence exists that the genetic polymorphis m of TPMT activity plays an important role during treatment with 6MP or azathioprine. There have been several reports of patients with TPMT de¢ciency developing severe haematological toxicity when treated with oral 6MP or azathioprine and most cases required a ¢ve-to tenfold dose reduction due to this toxicity. 2, 11, 12, 14, 22 TPMT activity also appears to play a role in the prognosis and survival of childhood ALL, re£ecting the therapeutic e¤cacy of treatment with 6MP. 2, 11, 12, 22 In view of the observations mentioned above, it is of importance to measure TPMT activity before starting thiopurine administration. Moreover, it may be useful to monitor TPMT activity during therapy, because its activity is often increased during therapy. 18 For this purpose, we have developed the HPLC-based enzymatic procedure described above. The procedure enabled measurement of TPMT activity in RBC, pMNC and leukaemic cell lines and showed good reproducibility for all three types of cells. Furthermore, our results showed that the neutralized supernatants may be stored for up to 3 weeks at 7808C before HPLC analysis.
In an earlier study, 23 using a radiochemical TLC procedure, we could not measure pMNC TPMT activity in nine out of 36 cases because these patients were leucopenic and we were unable to collect the necessary 5610 6 cells for the assay. However, with the present HPLC -based method, we can perform the assays with only 2610 6 cells. The HPLC-based method has other advantages over the radiochemical TLC method as well as improved sensitivity. First, it is more reliable because it avoids the liquid-liquid or solid-phase extraction used in the radiochemical TLC method. Second, it is a non-radiochemical procedure, so it is more compliant with current environmental protection policies. Third, it is less time -consuming and has a quicker sample throughput compared with the radiochemical method.
At present, for historical reasons, there is no uniform TPMT activity unit reported by laboratories and this is an issue that should be resolved.We chose to express TPMT activity based on the amount of RBC, since the RBC itself is the reactive unit. Expressing TPMT activity as pmol per mL RBC or per mmol haemoglobin is, in our opinion, unsatisfactory due to signi¢cant di¡erences in haematocrit and in the number of RBC per mL of blood in patients receiving chemotherapy, as described by Klemetsdal et al. 24 In comparison with earlier studies, we have established reference values in pmoles per number of RBC. Additionally, we measured the RBC lysate protein content of a representative subset of samples to relate these determinations to the number of lysed RBC. The correlation appeared to be fairly good.
In a number of studies it has been reported that tissues derived from male subjects have approximately 10% higher TPMT activity than those from female subjects. 25, 26 However, these ¢ndings have not been con¢rmed either by other authors 27, 28 or by this study, in which no age-or sex-related di¡erences were observed in our control group of 103 children and young adults. The distribution of RBC TPMT activity in our reference group (see Fig. 4 ) is consistent with the known polymorphism. We consider the`intermediate' TPMT activity to range from 5¢8 to 10 pmol/10 7 RBC per h (411¢1th centile), and individuals with such activity should provide specimens for mutation analysis. The`high' TPMT activities are considered to be 410 pmol/10 7 RBC per h (411¢1th centile). One child in the control group, a boy, had a very low TPMT activity of 1¢6 pmol/10 7 RBC per h; another boy had a very high activity of 50¢7 pmol/10 7 RBC per h.
As mentioned earlier, various studies have shown that low activity of TPMT may be a cause of azathioprine-or 6-MP-related bone marrow toxicity. Consequently, if an untreated patient is found to have a low TPMT activity, treatment should be initiated at a ¢ve-to tenfold lower dose of thiopurine than is used in patients with normal enzyme activity. The method described above is suitable for the rapid screening of such patients.
Conclusion
In conclusion, this paper describes an HPLC-based method that enables the measurement of TPMT activity to be made in large numbers of patients. It also describes TPMT activities measured using this method in a control group of 103 children and young adults aged less than 20 years. The range of activities observed may be used to identify cases with TPMT de¢ciency or they may be compared directly with the reference intervals described by other authors.
